


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+9.34%
+1.63%
-8.67%
+20.62%
-7.12%
TAK
Takeda Pharmaceutical Com
$13.70
Chart
$13.72 (-0.15%)
$15 (-8.67%)
$14.9 (-8.05%)
$13.38 (+2.39%)
TAK has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

TAK overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Earnings decline YoY
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
![]()
TAK Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
TAK Street Sentiment is not attractive and have negative views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is TAK current stock price?
What are TAK stock strengths?
What risks are associated with TAK stock?
When is TAK next earnings report?
What is TAK market cap and volume?
What is TAK's current Stock IQ?
Should I buy TAK stock right now?
Is TAK a Strong Buy right now?
What does a 'Strong Buy' rating mean for TAK?
What does a 'Strong Sell' rating mean for TAK?
What factors influence TAK's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+9.34%
+1.63%
-8.67%
+20.62%
-7.12%
TAK
Takeda Pharmaceutical Com
Current Price
$13.70

Chart
$13.72 (-0.15%)
$15 (-8.67%)
$14.9 (-8.05%)
$13.38 (+2.39%)
TAK Analysts Opinion
TAK Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Earnings decline YoY
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
![]()
TAK Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
TAK Street Sentiment is not attractive and have negative views on the near-term outlook
TAK has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels.
TAK Latest Analysis
Takeda Pharma H1 Net Profit Declines. Revenue Down 6.9% . (RTTNews) - Takeda Pharmaceutical Company Limited (TAK) reported first half net profit to owners of company of 112.4 billion yen down 40.0% from prior year. Earnings per share was 70.45 yen compared to 117.11 yen. Core operating profit was 639.2 billion yen down 11.2%. Core EPS
Thu Oct 30, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.